130 related articles for article (PubMed ID: 19606082)
1. A blueprint for randomized trials targeting phosphorus metabolism in chronic kidney disease.
Isakova T; Gutiérrez OM; Wolf M
Kidney Int; 2009 Oct; 76(7):705-16. PubMed ID: 19606082
[TBL] [Abstract][Full Text] [Related]
2. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
Lorenzo Sellares V; Torregrosa V
Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
[TBL] [Abstract][Full Text] [Related]
3. FGF23 in chronic kidney disease.
Wahl P; Wolf M
Adv Exp Med Biol; 2012; 728():107-25. PubMed ID: 22396166
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic interventions for chronic kidney disease-mineral and bone disorders: focus on mortality.
Block GA
Curr Opin Nephrol Hypertens; 2011 Jul; 20(4):376-81. PubMed ID: 21519253
[TBL] [Abstract][Full Text] [Related]
5. Fibroblast growth factor 23 and the future of phosphorus management.
Wolf M
Curr Opin Nephrol Hypertens; 2009 Nov; 18(6):463-8. PubMed ID: 19770756
[TBL] [Abstract][Full Text] [Related]
6. Forging forward with 10 burning questions on FGF23 in kidney disease.
Wolf M
J Am Soc Nephrol; 2010 Sep; 21(9):1427-35. PubMed ID: 20507943
[TBL] [Abstract][Full Text] [Related]
7. What would we like to know, and what do we not know about fibroblast growth factor 23?
Cozzolino M; Galassi A; Apetrii M; Covic A
J Nephrol; 2011; 24(6):696-706. PubMed ID: 21786227
[TBL] [Abstract][Full Text] [Related]
8. Prevention and control of phosphate retention/hyperphosphatemia in CKD-MBD: what is normal, when to start, and how to treat?
Martin KJ; González EA
Clin J Am Soc Nephrol; 2011 Feb; 6(2):440-6. PubMed ID: 21292848
[TBL] [Abstract][Full Text] [Related]
9. Phosphate binders in moderate chronic kidney disease: where do we stand?
Bellasi A; Cozzolino M; Adragao T; Di Iorio B; Russo D
J Nephrol; 2013; 26(6):993-1000. PubMed ID: 23543481
[TBL] [Abstract][Full Text] [Related]
10. Fibroblast growth factor 23 and disordered vitamin D metabolism in chronic kidney disease: updating the "trade-off" hypothesis.
Gutiérrez OM
Clin J Am Soc Nephrol; 2010 Sep; 5(9):1710-6. PubMed ID: 20507957
[TBL] [Abstract][Full Text] [Related]
11. [Disturbance of phosphorus metabolism in chronic kidney disease].
Komaba H; Fukagawa M
Clin Calcium; 2009 Feb; 19(2):166-72. PubMed ID: 19182354
[TBL] [Abstract][Full Text] [Related]
12. Survey of attitudes of physicians toward the current evaluation and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD).
Souqiyyeh MZ; Shaheen FA
Saudi J Kidney Dis Transpl; 2010 Jan; 21(1):93-101. PubMed ID: 20061700
[TBL] [Abstract][Full Text] [Related]
13. Early initiation of phosphate lowering dietary therapy in non-dialysis chronic kidney disease: a critical review.
Sigrist MK; Chiarelli G; Lim L; Levin A
J Ren Care; 2009 Mar; 35 Suppl 1():71-8. PubMed ID: 19222735
[TBL] [Abstract][Full Text] [Related]
14. Role of fibroblast growth factor 23 in phosphate homeostasis and pathogenesis of disordered mineral metabolism in chronic kidney disease.
Stubbs J; Liu S; Quarles LD
Semin Dial; 2007; 20(4):302-8. PubMed ID: 17635819
[TBL] [Abstract][Full Text] [Related]
15. Outcomes predicted by phosphorous in chronic kidney disease: a retrospective CKD-inception cohort study.
Smith DH; Johnson ES; Thorp ML; Petrik A; Yang X; Blough DK
Nephrol Dial Transplant; 2010 Jan; 25(1):166-74. PubMed ID: 19671593
[TBL] [Abstract][Full Text] [Related]
16. Phosphate in early chronic kidney disease: associations with clinical outcomes and a target to reduce cardiovascular risk.
Toussaint ND; Pedagogos E; Tan SJ; Badve SV; Hawley CM; Perkovic V; Elder GJ
Nephrology (Carlton); 2012 Jul; 17(5):433-44. PubMed ID: 22574672
[TBL] [Abstract][Full Text] [Related]
17. Trends in mineral metabolism: Kidney Early Evaluation Program (KEEP) and the National Health and Nutrition Examination Survey (NHANES) 1999-2004.
Vassalotti JA; Uribarri J; Chen SC; Li S; Wang C; Collins AJ; Calvo MS; Whaley-Connell AT; McCullough PA; Norris KC;
Am J Kidney Dis; 2008 Apr; 51(4 Suppl 2):S56-68. PubMed ID: 18359409
[TBL] [Abstract][Full Text] [Related]
18. Mineral metabolism disturbances in patients with chronic kidney disease.
Kestenbaum B; Belozeroff V
Eur J Clin Invest; 2007 Aug; 37(8):607-22. PubMed ID: 17635571
[TBL] [Abstract][Full Text] [Related]
19. Blood pressure, proteinuria, and phosphate as risk factors for progressive kidney disease: a hypothesis.
Cozzolino M; Gentile G; Mazzaferro S; Brancaccio D; Ruggenenti P; Remuzzi G
Am J Kidney Dis; 2013 Nov; 62(5):984-92. PubMed ID: 23664548
[TBL] [Abstract][Full Text] [Related]
20. Effect of a non-calcium-based phosphate binder on fibroblast growth factor 23 in chronic kidney disease.
Spatz C; Roe K; Lehman E; Verma N
Nephron Clin Pract; 2013; 123(1-2):61-6. PubMed ID: 23774446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
